An EHR-based Platform To Facilitate Outcomes and Research Methods in Cerebrovascular Diseases

Rate of antiplatelet medication use

Rate of antiplatelet therapy during hospitalization

Time frame: From date of hospitalization until the date of discharge, assessed up to 90 days

Rate of dual antiplatelet medication use for non-disabling IS and TIA events

Rate of aspirin and clopidogrel therapy for ischemic cerebrovascular diseases (IS or TIA) during hospitalization

Time frame: From date of hospitalization until the date of discharge, assessed up to 90 days

Rate of DVT prophylaxis ≤ 48 hours

Patients at risk for DVT (non-ambulatory) who received DVT prophylaxis by end of hospital 48 hours, including pneumatic compression, warfarin sodium, and novel oral anticoagulant

Time frame: 48 hours within hospitalization

Cerebrovascular assessment ≤ seven days

Cerebrovascular assessment (TCD, IVUS, brain CT or MR scan) within seven days of hospitalization

Time frame: 7 days within hospitalization

Statin therapy for LDL ≥100 mg/dL during hospitalization

Lipid lowering agent prescribed during hospitalization if LDL ≥ 100 mg/dL, if patient treated with lipid lowering agent prior to admission, or LDL not documented

Time frame: From date of hospitalization until the date of discharge, assessed up to 90 days

Rate of anticoagulation medication use for atrial fibrillation during hospitalization

Anticoagulation prescribed during hospitalization in patients with documented atrial fibrillation

Time frame: From date of hospitalization until the date of discharge, assessed up to 90 days

Rate of antithrombotic medication prescribtion at discharge

Antithrombotic therapy prescribed at discharge, including antiplatelet or anticoagulant therapy

Time frame: From date of hospitalization until the date of discharge, assessed up to 90 days

Rate of antihypertensive medication prescribtion for patients with hypertension at discharge

Antihypertension medication prescribed at discharge for patients with history of hypertension disease or hypertension disease documented during the hospitalization

Time frame: From date of hospitalization until the date of discharge, assessed up to 90 days

Rate of statin prescribtion for low-density lipoprotein≥100 mg/dL at discharge

Lipid lowering agent prescribed at discharge if LDL ≥ 100 mg/dL, if patient treated with lipid lowering agent prior to admission, or LDL not documented

Time frame: From date of hospitalization until the date of discharge, assessed up to 90 days

Rate of hypoglycaemia medication prescribtion for diabetes mellitus at discharge

Hypoglycemic medication prescribed at discharge for patients with history of diabetes mellitus or diabetes mellitus documented during the hospitalization

Time frame: From date of hospitalization until the date of discharge, assessed up to 90 days

Rate of anticoagulation medication prescribtion for atrial fibrillation at discharge

Anticoagulation prescribed at discharge in patients with documented atrial fibrillation

Time frame: From date of hospitalization until the date of discharge, assessed up to 90 days

Rate of thrombolytic therapy

Intravenous r-tPA in IS patients

Time frame: From date of hospitalization until the date of discharge, assessed up to 90 days

Rate of thrombectomy therapy

Thrombectomy therapy for IS patients

Time frame: From date of hospitalization until the date of discharge, assessed up to 90 days

Rate of DVT prophylaxis ≤ 48 hours for ICH

Patients with ICH at risk for DVT (non-ambulatory) who received DVT prophylaxis by end of hospital 48 hours, including pneumatic compression.

Time frame: 48 hours within hospitalization

Rate of antihypertensive medicine use for ICH patients with hypertension at discharge

Antihypertension medication prescribed at discharge for ICH patients with history of hypertension disease or hypertension disease documented during the hospitalization

Time frame: From date of hospitalization until the date of discharge, assessed up to 90 days

Rate of hypoglycemia medication use for ICH patients with diabetes mellitus at discharge

Hypoglycemic medication prescribed at discharge for ICH patients with history of diabetes mellitus or diabetes mellitus documented during the hospitalization

Time frame: From date of hospitalization until the date of discharge, assessed up to 90 days

Rate of neurosurgery for ICH patients

Neurosurgery of ICH include removal of hematoma by craniotomy, aspiration of hematoma by drilling, decompressive craniectomy, ventriculocentesis and drainage, other removal of intracranial hematoma

Time frame: From date of hospitalization until the date of discharge, assessed up to 90 days

Rate of DVT prophylaxis ≤ 48 hours for SAH

Patients with SAH at risk for DVT (non-ambulatory) who received DVT prophylaxis by end of hospital 48 hours, including pneumatic compression

Time frame: 48 hours within hospitalization

Rate of antihypertensive medicine use for SAH patients with hypertension at discharge

Antihypertension medication prescribed at discharge for SAN patients with history of hypertension disease or hypertension disease documented during the hospitalization

Time frame: From date of hospitalization until the date of discharge, assessed up to 90 days

Rate of hypoglycemia medication use for SAH patients with diabetes mellitus at discharge

Hypoglycemic medication prescribed at discharge for SAH patients with history of diabetes mellitus or diabetes mellitus documented during the hospitalization

Time frame: From date of hospitalization until the date of discharge, assessed up to 90 days

Rate of neurosurgery for SAH patients

Neurosurgery of SAH include aneurysm clipping, endovascular embolization of aneurysm, extraventricular shunt

Time frame: From date of hospitalization until the date of discharge, assessed up to 90 days